Frank Kayser

2.5k total citations
33 papers, 1.4k citations indexed

About

Frank Kayser is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Frank Kayser has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Frank Kayser's work include Receptor Mechanisms and Signaling (6 papers), Axial and Atropisomeric Chirality Synthesis (4 papers) and Chemical Synthesis and Analysis (4 papers). Frank Kayser is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Axial and Atropisomeric Chirality Synthesis (4 papers) and Chemical Synthesis and Analysis (4 papers). Frank Kayser collaborates with scholars based in United States, Germany and Libya. Frank Kayser's co-authors include Bruce H. Lipshutz, Mario Cardozo, Konstantin Siegmann, Xian‐Yun Jiao, Nigel P.C. Walker, Yingcai Wang, David J. Kopecky, Jiwen Liu, Shyun Li and TaeWeon Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Frank Kayser

33 papers receiving 1.4k citations

Peers

Countries citing papers authored by Frank Kayser

Since Specialization

Citations

This map shows the geographic impact of Frank Kayser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Kayser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Kayser more than expected).

Fields of papers citing papers by Frank Kayser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Kayser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Kayser. The network helps show where Frank Kayser may publish in the future.

Co-authorship network of co-authors of Frank Kayser

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Kayser. A scholar is included among the top collaborators of Frank Kayser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Kayser. Frank Kayser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction 2019 ·Nature Communications ·(unknown), Joshua P. Taygerly, Kathleen Boyle, Stephen E. Basham, (unknown), Yan Lou, Thomas J. Cummins, Stephanie Yung, Szerenke Kiss Von Soly, Frank Kayser, John Kuriyan, Michael Rapé, Mario Cardozo, Mark A. Gallop, Neil Bence, Paul A. Barsanti, Anjanabha Saha	147
2	Discovery and optimization of 5-(2-((1-(phenylsulfonyl)-1,2,3,4-tetrahydroquinolin-7-yl)oxy)pyridin-4-yl)-1,2,4-oxadiazoles as novel gpr119 agonists 2014 ·Bioorganic & Medicinal Chemistry Letters ·Yingcai Wang, Ming Yu, Jiang Zhu, (unknown), Frank Kayser, Julio C. Medina, (unknown), Marion Conn, Bei Shan, Mark P. Grillo, (unknown), Peter Coward	9
3	Structure-assisted discovery of the first non-retinoid ligands for Retinol-Binding Protein 4 2014 ·Bioorganic & Medicinal Chemistry Letters ·Yingcai Wang, Richard Connors, Pingchen Fan, Xiaodong Wang, Zhongyu Wang, Jiwen Liu, Frank Kayser, Julio C. Medina, Sheree Johnstone, Haoda Xu, (unknown), Nigel P.C. Walker, Marion Conn, Ying Zhang, Qingxiang Liu, Mark P. Grillo, Alykhan Motani, Peter Coward, Zhulun Wang	14
4	Optimization beyond AMG 232: Discovery and SAR of sulfonamides on a piperidinone scaffold as potent inhibitors of the MDM2-p53 protein–protein interaction 2014 ·Bioorganic & Medicinal Chemistry Letters ·Yingcai Wang, Jieping Zhu, Jiwen Liu, Xiaoqi Chen, Jeff Mihalic, (unknown), Ming Yu, Daqing Sun, Frank Kayser, Lawrence R. McGee, Mei-Chu Lo, Ada Chen, Jing Zhou, Qiuping Ye, Xin Huang, Alexander Long, P. Yakowec, Jonathan D. Oliner, Steven H. Olson, Julio C. Medina	13
5	Discovery and optimization of N-(3-(1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-4-yloxy)phenyl)benzenesulfonamides as novel GPR119 agonists 2013 ·Bioorganic & Medicinal Chemistry Letters ·Ming Yu, Jian Zhang, Yingcai Wang, Jiang Zhu, Frank Kayser, Julio C. Medina, (unknown), Marion Conn, Bei Shan, Mark P. Grillo, Peter Coward, Jiwen Liu	13
6	Synthesis and optimization of substituted furo[2,3-d]-pyrimidin-4-amines and 7H-pyrrolo[2,3-d]pyrimidin-4-amines as ACK1 inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Xian‐Yun Jiao, David J. Kopecky, Jinsong Liu, Jinqian Liu, Juan C. Jaén, Mario Cardozo, Rajiv Sharma, Nigel P.C. Walker, Holger Wesche, Shyun Li, Ellyn Farrelly, Shou-Hua Xiao, Zhulun Wang, Frank Kayser	58
7	Discovery and optimization of a series of liver X receptor antagonists 2012 ·Bioorganic & Medicinal Chemistry Letters ·Xian‐Yun Jiao, David J. Kopecky, (unknown), Derek E. Piper, Marc Labelle, (unknown), Martin Harrison, Stuart A. Jones, Juan C. Jaén, Andrew K. Shiau, (unknown), Jean Danao, (unknown), Peter Coward, Frank Kayser	16
8	Discovery of a new binding mode for a series of liver X receptor agonists 2012 ·Bioorganic & Medicinal Chemistry Letters ·David J. Kopecky, (unknown), (unknown), (unknown), Marc Labelle, Derek E. Piper, Peter Coward, Andrew K. Shiau, (unknown), Jean Danao, (unknown), Juan C. Jaén, Frank Kayser	10
9	Novel pyrrolidine melanin-concentrating hormone receptor 1 antagonists with reduced hERG inhibition 2011 ·Bioorganic & Medicinal Chemistry Letters ·Brian M. Fox, Reina Natero, (unknown), Richard Connors, Philip M. Roveto, Holger Beckmann, (unknown), (unknown), Shou-Hua Xiao, Frank Kayser	13
10	Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Darin J. Gustin, Zhihua Ma, Xiaoshan Min, Yihong Li, (unknown), Cristiano R. W. Guimarães, Amy C. Porter, Michelle Lindström, (unknown), Guifen Xu, Timothy J. Carlson, Shou-Hua Xiao, (unknown), Richard Connors, Zhulun Wang, Frank Kayser	38
11	Discovery of pyrrolopyridazines as novel DGAT1 inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Brian M. Fox, Kiyosei Iio, Kexue Li, (unknown), Takashi Inaba, Simon Jackson, Shoichi Sagawa, Bei Shan, Masahiro Tanaka, (unknown), Frank Kayser	23
12	The first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulators 2009 ·Bioorganic & Medicinal Chemistry Letters ·Yingcai Wang, Xian‐Yun Jiao, Frank Kayser, Jiwen Liu, Zhongyu Wang, (unknown), (unknown), Jennifer Weiszmann, Hongfei Ge, Hui Tian, Simon Wong, Ralf Schwandner, TaeWeon Lee, Yang Li	83
13	Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·David J. Kopecky, Xiaolin Hao, Yi Chen, Jiasheng Fu, Xian‐Yun Jiao, Juan C. Jaén, Mario Cardozo, Jinsong Liu, Zhulun Wang, Nigel P.C. Walker, Holger Wesche, Shyun Li, Ellyn Farrelly, Shou-Hua Xiao, Frank Kayser	31
14	Identification and Functional Characterization of Allosteric Agonists for the G Protein-Coupled Receptor FFA2 2008 ·Molecular Pharmacology ·TaeWeon Lee, Ralf Schwandner, Gayathri Swaminath, Jennifer Weiszmann, Mario Cardozo, (unknown), Peter Jaeckel, Hongfei Ge, Yingcai Wang, Xian‐Yun Jiao, Jiwen Liu, Frank Kayser, Hui Tian, Yang Li	126
15	An ultrasensitive high-throughput electrochemiluminescence immunoassay for the Cdc42-associated protein tyrosine kinase ACK1 2007 ·Analytical Biochemistry ·Shou-Hua Xiao, Ellyn Farrelly, John V. Anzola, (unknown), Xian‐Yun Jiao, Jinqian Liu, (unknown), Shyun Li, Linda Huang, Rajiv Sharma, Frank Kayser, Holger Wesche, Stephen W. Young	8
16	Potent Kv1.3 inhibitors from correolide—modification of the C18 position 2004 ·Bioorganic & Medicinal Chemistry Letters ·Jianming Bao, (unknown), Frank Kayser, (unknown), Robert K. Baker, George A. Doss, John P. Felix, Randal M. Bugianesi, Robert S. Slaughter, Gregory J. Kaczorowski, María L. García, Sookhee Ha, (unknown), Gloria C. Koo, Kashmira Shah, Marty S. Springer, Mary Jo Staruch, William H. Parsons, Kathleen M. Rupprecht	18
17	Benzamide derivatives as blockers of Kv1.3 ion channel 2003 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Jianming Bao, María L. García, (unknown), (unknown), Gregory J. Kaczorowski, Frank Kayser, Gloria C. Koo, (unknown), William A. Schmalhofer, Kashmira Shah, Peter M. Sinclair, Robert S. Slaughter, Marty S. Springer, Mary Jo Staruch, Nancy N. Tsou, Frederick Wong, William H. Parsons, Kathleen M. Rupprecht	25
18	Identification and Biochemical Characterization of a Novel Nortriterpene Inhibitor of the Human Lymphocyte Voltage-Gated Potassium Channel, Kv1.3 1999 ·Biochemistry ·John P. Felix, Randal M. Bugianesi, William A. Schmalhofer, Robert P. Borris, Michael Goetz, Otto D. Hensens, Jianming Bao, Frank Kayser, William H. Parsons, Kathleen M. Rupprecht, María L. García, Gregory J. Kaczorowski, Robert S. Slaughter	88
19	Some observations on the solution composition of Gilman reagent (“R2CuLi”) 1993 ·Tetrahedron Letters ·Bruce H. Lipshutz, Frank Kayser, Konstantin Siegmann	6
20	Cycloaddition reactions of λ-amino α,β-didehydro amino acid esters: a test case for the principle of 1,3-allylic strain 1992 ·Tetrahedron Letters ·Manfred T. Reetz, Frank Kayser, Klaus Harms	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact